The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection.
about
Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapyPrevention of Hepatitis B reactivation in the setting of immunosuppressionEvolution of hepatitis B management in kidney transplantationHepatitis B and Renal Disease.Hepatitis B in transplantation.Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis.Management of hepatitis C infection in renal transplant recipients.Reduced antibody reactivity to hepatitis C virus antigens in hemodialysis patients coinfected with hepatitis B virus.Increased risk of hepatic complications in kidney transplantation with chronic virus hepatitis infection: A nationwide population-based cohort studyPretransplant Hepatitis B Viral Infection Increases Risk of Death After Kidney Transplantation: A Multicenter Cohort Study in Korea.Viral infection after renal transplantation: surveillance and management.Hepatitis B virus infection and renal transplantationChronic viral hepatitis in kidney transplantation.Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease.Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(-) donors.Outcome of hepatitis B and C virus-associated hepatocellular carcinoma occurring after renal transplantation.Hepatitis B in renal transplant patients.Entecavir treatment in kidney transplant recipients infected with hepatitis B.Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection.An open-label study of lamivudine for chronic hepatitis B in six patients with chronic renal failure before and after kidney transplantation.Prognostic implications of recipient or donor hepatitis B seropositivity in thoracic transplantation: analysis of 426 hepatitis B surface antigen-positive recipients.Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy.Hepatitis B surface antigen-positive organ transplantation recipients: can lamivudine alter their fate?Lamivudine therapy for hepatitis B in renal transplantation.Prospective study on lamivudine-resistant hepatitis B in renal allograft recipients.Clinical and immunological features of very long-term survivors with a single renal transplant.Long-term effects of prophylactic and therapeutic lamivudine treatments in hepatitis B surface antigen-positive renal allograft recipients.Outcomes of kidney transplantation in patients with hepatitis B virus infection: A systematic review and meta-analysis.
P2860
Q24240881-D648D0A3-0206-46AA-833B-BB34ECD037F3Q26747023-3BB9F2B3-6965-46D3-8130-914867D47C07Q26995706-CA81AB34-F5A6-4D1D-9606-9D24C0E1190EQ33819104-75965061-55D4-4D6F-9B23-F7B76E992875Q34294933-42934677-EB75-4748-BFCF-DEC25A5B28E3Q34734311-812CC51D-622E-4F19-BCEC-3187C48CC270Q34740589-84B61E60-3634-4B98-BC5E-BC5E94664B08Q35231658-DFAC348B-3951-467A-9B0E-B698FF186372Q36595414-D7D3B840-61B9-4EB0-A7A0-4FACB756A498Q36992877-24E449CF-0F33-40C0-A462-453174E2C4B6Q37097708-3E89B49C-C688-4538-B290-7A23F9D0DC87Q37780176-3C8FB67B-4FD8-4B88-B604-E5D115DABF40Q37833898-1485879D-4B4A-48AA-9192-DDBF1358A836Q38168296-BD379B59-B985-49F2-9EF6-C4E07951AD6BQ40324574-D80D0A8A-4B16-495C-A09B-03ED345258A7Q40423982-3F4AD61B-722B-49FD-922F-6EE3F6B5D83EQ41690591-49AE5586-F2BF-4AE4-9B8D-EE5FF74845C8Q42209408-F1854940-28CA-4F0F-82A5-1E8E1DF5FDDCQ42231500-1B3E5C91-8DD1-47F8-87E9-1FF246B9F870Q42640615-36E4FBEB-7F8D-4F86-8AD2-2B6F282C9A31Q42669414-4BAD32C8-75BD-4964-AC66-7A357ABEEF1BQ43678974-EA256BFC-B68C-4A44-9A3B-1A8F4BCEF2B7Q43762350-24BACDE2-B16C-46BC-9AAF-E1A586760AE0Q43888276-682A3D50-74EC-4438-9AB2-6F3437613019Q44935463-E489C1DA-AA77-4BA9-B906-CD15DA3AACEBQ50966306-F4C8896F-06D9-42EF-BECD-4456501207E2Q51877261-979E912E-72FB-4FE0-9CF1-8742FFD4398DQ53274315-629B0A7B-C58E-4D12-A5BE-8962A2A9C135
P2860
The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
The long-term virologic and pa ...... c hepatitis B virus infection.
@en
The long-term virologic and pa ...... c hepatitis B virus infection.
@nl
type
label
The long-term virologic and pa ...... c hepatitis B virus infection.
@en
The long-term virologic and pa ...... c hepatitis B virus infection.
@nl
prefLabel
The long-term virologic and pa ...... c hepatitis B virus infection.
@en
The long-term virologic and pa ...... c hepatitis B virus infection.
@nl
P2093
P1433
P1476
The long-term virologic and pa ...... c hepatitis B virus infection.
@en
P2093
Fornairon S
Legendre C
Mamzer-Bruneel MF
P304
P356
10.1097/00007890-199607270-00025
P577
1996-07-01T00:00:00Z